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Abstract Antioxidants are known to exert a preventive activity
against degenerative diseases. Here, we investigated the mech-
anism of action of three antioxidants: resveratrol, which causes
di¡erentiation of HL-60 cells, and hydroxytyrosol and pyrroli-
dine dithiocarbamate which, in the same model system, activate
apoptosis. The expression pro¢le of hydroxytyrosol-treated cells
showed the up-regulation of several genes, including c-jun and
egr1. Pyrrolidine dithiocarbamate activates both genes, while
resveratrol increases uniquely egr1. A selective modulation of
signalling pathway explained this ¢nding. All antioxidants up-
regulate Erk1/2, while only hydroxytyrosol and pyrrolidine di-
thiocarbamate activate c-Jun N-terminal kinase (JNK). Since
JNK induces apoptosis by Bcl-2 phosphorylation, we investi-
gated this event. Bcl-2 phosphorylation was increased by hy-
droxytyrosol and pyrrolidine dithiocarbamate and not by resve-
ratrol. Our results indicate that the di¡erent phenotypical
e¡ects of antioxidants correlate with modulation of selective
transduction pathways.
2 2002 Published by Elsevier Science B.V. on behalf of the
Federation of European Biochemical Societies.
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1. Introduction
Numerous epidemiological data indicate that an increased
dietary intake of antioxidants, including vitamins C and E,
L-carotene and polyphenols, is associated with a diminished
risk of cardiovascular diseases [1,2] and cancer [3,4]. Although
the precise mechanism of action of these compounds is not
understood, several lines of evidence suggest that they mainly
prevent the free radical-dependent macromolecule damages,
thus reducing the accumulation of structural and functional
alterations in vivo [5].
Conversely, it appears clear that the biological activities of
antioxidants might not be simply related to their scavenger
capability. Indeed, these molecules are able to induce many
phenotypical e¡ects, ranging from cell growth arrest to acti-
vation of di¡erentiation, induction of (or, conversely, resis-
tance to) apoptosis and, in a few instances, stimulation of
proliferation [6^12].
We previously described the e¡ect of three antioxidants,
namely resveratrol, hydroxytyrosol (dihydroxyphenylethanol,
DPE) and pyrrolidine dithiocarbamate (PDTC) (Fig. 1) on
the growth and survival of HL-60 cells. Resveratrol is a
well-known phytoalexin occurring at high concentration in
grape skin and red wine [13], while DPE is a polyphenol
present in extra virgin olive oil [14]. Both compounds exert
several protective e¡ects, either in vivo or in vitro [15^18],
which could explain, at least in part, the bene¢cial properties
of the ‘Mediterranean diet’. PDTC, a synthetic antioxidant,
has attracted considerable interest since it is able to enhance
the anticancer ability of 5-£uorouracil [19]. Particularly, the
treatment with PDTC and 5-£uorouracil completely prevented
the growth of tumor xenografts in athymic mice [19].
The three molecules exert di¡erent e¡ects on HL-60 cells.
We demonstrated that DPE [20] and PDTC [21] are able to
activate apoptosis by causing cytochrome c release from mi-
tochondria, while resveratrol induces di¡erentiation towards a
myelo-monocytic lineage by blocking the cell cycle at the
checkpoint between SCG2 transition [22].
These ¢ndings moved us to investigate the molecular bases
of the distinct phenotypical e¡ects by a comparative approach
employing as our model system HL-60 cells. This cell line was
selected since it has been widely employed in studies devoted
to the evaluation of antiproliferative, di¡erentiation and apo-
ptotic e¡ects of potentially active molecules. Also, and most
important, we have previously characterized in detail the phe-
notypical e¡ects of all three molecules on these cells.
Initially, we studied the activity of DPE on gene transcrip-
tion by means of cDNA arrays. Then, we selected the genes
mostly activated and investigated their regulation by PDTC
and resveratrol. This approach allowed us to identify di¡er-
ences of the antioxidant e¡ects on the signalling pathways.
Altogether, our results permit us to conclude that the ob-
served di¡erent e¡ects on the phenotype of the same cell
line are, at least in part, due to speci¢c transduction pathway
modulations.
2. Materials and methods
2.1. Cell treatments
HL-60 cells were obtained and grown as in [22]. PDTC, tyrosol,
homogentisic acid and resveratrol were obtained from Sigma Chem-
ical Company (St. Louis, MO, USA). 2-(3,4-Dihydroxyphenyl)ethanol
(DPE) was from G.F. Montedoro, University of Perugia, Italy. Re-
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sveratrol and DPE were suspended in dimethylsulfoxide at a concen-
tration of 100 mM and stored for brief periods at 380‡C, while
PDTC solution (100 mM in dimethylsulfoxide) was freshly prepared
for each experiment. PD98059 (Erk1/2 inhibitor), SB203580 (p38 ki-
nase inhibitor), KN62 (Ca2þ/calmodulin kinase inhibitor) and H8
(inhibitor of protein kinase A/C (PKA/PKC)) were from BioMol Re-
search Laboratories (Plymouth Meeting, PA, USA). The molecules
were directly added to cultures, while control cells contained the sol-
vent alone.
2.2. cDNA expression array and reverse transcription-polymerase chain
reaction (RT-PCR) analysis
Total RNA was prepared using the Atlas pure total RNA isolation
kit (Clontech, Palo Alto, CA, USA). For analyzing gene expression in
HL-60 cells, the Atlas cDNA expression array (cat. # 7740-1) was
employed as described in the user’s manual and in [23]. Semiquanti-
tative RT-PCR analyses were carried out as described in [23]. Primer
sequences used for c-Jun, Egr1, GADD45 and RAB2 were obtained
from Clontech, while the primers for glyceraldehyde 3-phosphate de-
hydrogenase (GAPDH) were as in [23]. Each experiment was per-
formed at least in triplicate.
2.3. Immunochemical techniques and c-Jun N-terminal kinase (JNK)
assay
Monoclonal antibodies to phospho-Erk (Tyr204) were provided by
Santa Cruz Biotechnologies (Santa Cruz, CA, USA). Polyclonal anti-
bodies to Bcl-2, phospho-Bcl-2 (Ser70), c-Jun, phospho-c-Jun (Ser63),
JNK, Egr1 and Erk1/2 were from Santa Cruz. Immunoblotting were
performed as in [24].
JNK activity was assayed as reported below. Brie£y, equal amounts
(0.5^1 mg) of cell extract were incubated for 4 h with anti-JNK poly-
clonal antibodies at room temperature. The mixtures were added with
agarose A-protein, incubated for a further 2 h and centrifuged. The
precipitates were washed and incubated with recombinant c-Jun pro-
tein (amino acids 1^79, Santa Cruz) for 30 min at 37‡C. The reaction
mixtures were then separated by sodium dodecyl sulfate electropho-
resis, transferred to nitrocellulose and incubated with anti-phospho-c-
Jun antibodies.
3. Results and discussion
3.1. E¡ect of DPE on gene expression
In order to identify genes regulated by DPE, we analyzed
its activity on gene transcription by means of cDNA expres-
sion arrays. HL-60 cells were treated with 100 WM DPE for
5 h. It is to be underlined that this concentration is probably
reached in vivo [25] since olive oil DPE content is up to 3 mM
[26]. Moreover, we have previously showed that 100 WM DPE
is able to cause the release of cytochrome c from mitochon-
dria after 6 h and, thereafter, to induce apoptosis within 24 h
[20]. The expression array experiments were performed in the
presence of cycloheximide to identify only direct transcrip-
tional e¡ects and to rule out the involvement of de novo syn-
thesized proteins. Examples of the primary data, regarding
some genes of interest (see below), are reported in Fig. 2A.
Table 1 shows a short summary of the expression pro¢les
upon addition of DPE to growing HL-60 cells ; the fold in-
duction values are a mean of three independent experiments.
The genes reported are those showing the most marked up-
regulation. Interestingly, only few genes are down-regulated
(particularly Cdc25A and NIP1).
As reported in the table, several of the overexpressed genes
(c-jun, egr1, GADD45) control important cellular processes,
i.e. cell cycle, signal transduction, DNA repair and genome
transcription, and thus they might be responsible, at least in
part, for the DPE-induced phenotype. The e¡ect of DPE on
four of the up-modulated gene was also veri¢ed by RT-PCR
in independent experiments (Fig. 2B). The results agree with
those obtained by cDNA arrays.
3.2. Comparative e¡ect of resveratrol, DPE and PDTC on the
selected genes
Among the genes identi¢ed, we selected for further studies
c-jun and egr1, since they encode transcription factors control-
ling key processes, like cell cycle arrest, di¡erentiation and
apoptosis [27^30].
Preliminarily, we investigated the e¡ects of DPE on c-jun
transcription and observed that the phenomenon was both
time- and dose-dependent (data not reported). The induction
of an e⁄cacious c-Jun synthesis was then con¢rmed at the
protein level (Fig. 3A,C), thus demonstrating a complete cor-
respondence between the transcription and the translation of
the gene. The analysis of resveratrol and PDTC e¡ects on
c-jun expression (Fig. 3B,C) demonstrates that the synthetic
antioxidant (PDTC) markedly stimulates the up-regulation of
gene transcription while resveratrol causes a very scarce in-
duction of the gene. Finally, the phosphorylation of the newly
synthesized c-Jun protein was demonstrable by using speci¢cFig. 1. Chemical formulas of PDTC, DPE and resveratrol.
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Fig. 2. E¡ect of DPE on gene expression. HL-60 cells were cultured
with 100 WM DPE for 5 h in the presence of cycloheximide (36
WM). Untreated cells are indicated as Con. Then, total RNA was
prepared and employed for investigating the expression pro¢le by
cDNA array or by RT-PCR. A: Details of cDNA arrays showing
the expression level of egr1 and c-jun. B: Expression of the reported
gene by RT-PCR.
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antibodies (Fig. 3D), thus allowing two conclusions: (i) c-Jun
was fully functional and (ii) JNKs were active.
In all these experiments the employed concentration of
resveratrol and PDTC (30 WM) was similar to (or lower
than) that used in several studies reported in literature [15^
20,22].
The data obtained indicate a correlation between the capa-
bility of antioxidants of inducing apoptosis and the activation
of signal transduction pathways leading to c-jun gene expres-
sion. Moreover, it is possible, although not proved by our
experiments, that the accumulation of c-Jun is involved in
DPE- and PDTC-dependent cell death [31].
In order to evaluate our hypothesis, we studied the e¡ect of
two DPE structural analogs, which are unable to activate ap-
optosis [20], on c-jun expression. Particularly, we compared
the e¡ect of DPE with that of tyrosol and homogentisic
acid. Both the analogs neither induced programmed cell death
[23] nor up-regulated c-jun transcription (Fig. 3E), thus con-
¢rming the hypothesis of a possible correlation between these
two events.
Table 1
Human genes mostly induced by DPE
GenBank accession number Description Fold induction Function
M62829 egr1 5R 1 Transcription factor
J04111 c-jun 4R 1 Transcription factor
M60974 GADD45 3.5R 1 DNA repair and proliferation control
M28213 RAB2 3R 1 Signal Transducer
X92812 TGFL 3R 1 Growth factor
X86779 Fast kinase 3R 1 Apoptosis
HL-60 cells were treated for 5 h with or without 100 WM DPE in the presence of 36 WM cycloheximide. The expression pro¢le analysis was
performed as in Section 2.
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Fig. 3. E¡ect of DPE, PDTC and resveratrol on c-jun expression. A: HL-60 cells were cultured in the presence of the indicated amounts of
DPE for 8 h. Then, the c-Jun level was determined by immunoblotting. Con, untreated cells. B: HL-60 cells were cultured with 30 WM PDTC
and 30 WM resveratrol (Res) in the presence of cycloheximide (36 WM) for di¡erent time periods. Then, c-jun expression was determined by
RT-PCR. C: HL-60 cells were cultured without (Con) or with 100 WM DPE, 30 WM PDTC or 30 WM Res for 8 h. The c-Jun level was de-
termined by immunoblotting. D: HL-60 cells were cultured with DPE for 8 h. The phospho-c-Jun level was determined by immunoblotting.
E: HL-60 cells were cultured with the indicated amounts of tyrosol (Tyr), homogentisic acid (Homo), DPE and PDTC for 8 h. Then, the level
of c-Jun was determined by immunoblotting.
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Then, we analyzed the e¡ects of DPE, resveratrol and
PDTC on egr1 up-regulation. In this case, all the compounds
were able to activate the expression of the gene (Fig. 4A,B).
Comparing the level of the induced protein, the e¡ect of res-
veratrol, on the basis of the immunoblotting signal, was stron-
ger than that of DPE. Moreover, in the case of resveratrol the
Egr1 up-regulation persists, at least, up to 24 h (Fig. 4C). This
result is quite surprising since, generally, the activation of the
egr1 gene is rapid but transient [32,33]. The data on DPE also
indicate a marked increase in Egr1 protein (Fig. 4C), although
the 24 h point could not be taken into account due to the
apoptosis of cells.
3.3. Modulation of signal transduction pathways by resveratrol,
DPE and PDTC
The above reported ¢ndings prompted us to analyze the
activity of the antioxidants on signalling pathways which
might induce c-jun and egr1. By using a series of kinase in-
hibitors, we demonstrated that DPE-dependent egr1 up-regu-
lation is due exclusively to Erk1/2 pathway activation (Fig.
5A). Identical ¢ndings were obtained by studying egr1 mod-
ulation by resveratrol and PDTC (data not reported). The
result allows the hypothesis that, at least in HL-60 cells, all
the antioxidants activate the Erk1/2 pathway. This view was
con¢rmed by the direct analysis of the phosphorylated forms
of the kinases by immunoblotting, after DPE stimulation (Fig.
5B). While the inhibition of this pathway abrogates the up-
regulation of egr1, it was ine⁄cacious towards c-jun up-regu-
lation, which was not a¡ected by any of the inhibitors em-
ployed (Fig. 5C). This permits us to exclude a role of Erk1/2,
p38 kinase, PKA, PKC and Ca2þ/calmodulin kinase in the
antioxidant-dependent c-Jun accumulation.
Since there are no speci¢c JNK inhibitors available we
could not know whether the stimulation of c-jun transcription
was due to the activation of the JNK pathway. Moreover,
since resveratrol did not induce c-jun expression under the
employed experimental conditions, it is conceivable that the
phytoalexin did not activate JNK. In order to address this
view, we analyzed JNK activity by an enzymatic assay. We
observed a signi¢cant JNK activation by DPE (Fig. 5D) and
PDTC (not reported) but not by resveratrol (Fig. 5D). This
result suggests a possible correlation between the apoptotic
e¡ect exerted by the two antioxidants (DPE and PDTC)
and JNK activation. In accordance with this mechanism,
resveratrol, which does not activate JNK, does not induce
programmed cell death.
While the pro-apoptotic e¡ect of JNK activation has been
widely reported in the literature [34], it is not de¢nitely estab-
lished whether c-Jun accumulation might correlate with this
activity. c-Jun up-regulation causes a complex array of phe-
notypical e¡ects, including proliferation, cell death and di¡er-
entiation [27,28,31]. Thus, we were looking for other putative
molecular mechanism(s) linking antioxidantCJNK activa-
tionCapoptosis.
In this scenario, it is important to underline that one of the
e¡ectors of JNK-related cell death is the phosphorylation (at
Ser70) and inactivation of Bcl-2 [35,36]. This protein exerts its
anti-apoptotic e¡ect by maintaining the structure of the ex-
ternal membrane of mitochondria and, in turn, by hampering
the release of cytochrome c [34]. Therefore, we evaluated the
e¡ect of DPE, resveratrol and PDTC on Bcl-2 phosphory-
lation. As shown in Fig. 5E, while PDTC and DPE markedly
increased Bcl-2 phosphorylation, resveratrol did not modulate
this event.
Our study reports a signi¢cant number of novel observa-
tions. First, we demonstrated, for the ¢rst time, that resvera-
trol, DPE and PDTC enhance directly the expression of a
pivotal transcriptional factor, i.e. egr1, while only DPE and
PDTC up-regulate the transcription of the c-jun gene. Second,
the three antioxidants modulate, in a di¡erent fashion, kinases
involved in two transduction pathways, namely Erk1/2 and
JNK. Third, DPE and PDTC, but not resveratrol, activate
the phosphorylation of Bcl-2.
When we compare these molecular events with the antioxi-
dant-dependent phenotypical e¡ects, it appears probable that
a di¡erent regulation of signal transduction pathways might
be the principal cause of di¡erent cellular e¡ects. This also
strongly suggests that speci¢c molecular interactions, only
partially related to the general scavenger capability, are at
the basis of the phenotype observed. Moreover, the molecular
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Fig. 4. E¡ects of DPE, PDTC and resveratrol on egr1 expression.
A: HL-60 cells were cultured with 100 WM DPE in the presence of
cycloheximide (36 WM) for the reported time periods. egr1 expres-
sion was evaluated by RT-PCR. MW, molecular weight. B: HL-60
cells were cultured with 30 WM PDTC and 30 WM resveratrol (Res)
in the presence of cycloheximide for di¡erent time periods. egr1 ex-
pression was evaluated by RT-PCR. C: HL-60 cells were cultured
with 100 WM DPE and 30 WM Res for the reported time periods.
Egr1 level was determined by immunoblotting. Importantly, the
point at 24 h for DPE was not reported due to the death of cells
by apoptosis.
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basis of the observed di¡erences will also be bene¢cial for a
rational therapeutic use of antioxidants.
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